chadox1 n-cov vaccine

Vaccineexperimental

Clinical trial activity

7 trials · 11 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
4
Phase 3
2
Phase 4
0

Earliest trial started Apr 30, 2020 (NCT04324606)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2022

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • SARS-CoV-2Immunity, active

    SARS-CoV-2 immunity, active

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05293665Phase 3Mar 16, 2022Coalition for Epidemic Preparedness Innovations, Syneos Health, Vaxxinity, Inc.
NCT05074368N/AJul 6, 2021National Taiwan University, Taoyuan General Hospital
NCT05324319Phase 2Jun 15, 2021Medical University of Vienna
NCT04816019Phase 1Apr 1, 2021University of Oxford
NCT04444674Phase 1/Phase 2 (Phase 2)Jun 24, 2020Bill and Melinda Gates Foundation, Medical Research Council, South Africa, University of Oxford, University of the Witwatersrand, Wits Health Consortium (Pty) Ltd
NCT04400838Phase 2/Phase 3 (Phase 3)May 31, 2020University of Oxford
NCT04324606Phase 1/Phase 2 (Phase 2)Apr 30, 2020University of Oxford
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of OxfordAcademic/Hospital4432020
Bill and Melinda Gates FoundationAcademic/Hospital1012020
Coalition for Epidemic Preparedness InnovationsAcademic/Hospital1012022
Medical Research Council, South AfricaGovernment1012020
Medical University of ViennaAcademic/Hospital1112021
National Taiwan UniversityAcademic/Hospital1112021
Syneos HealthFor profit1012022
Taoyuan General HospitalAcademic/Hospital1012021
University of the WitwatersrandAcademic/Hospital1012020
Vaxxinity, Inc.For profit1112022
Wits Health Consortium (Pty) LtdAcademic/Hospital1012020
11 organizations
Page 1 / 1